Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 34

Sort by

Sort Order Select

Journal Articles

Age Is a Crucial Determinant of GFRS with Incidence of Severe Chronic GVHD Reducing over Time in Haemopoietic Cell Transplantation for Transfusion Dependent Thalassaemia: Real World Data from 2010-2021. an Analysis of the European Society for Blood and Bone Marrow Transplantation Hemoglobinopathy Working Party

Donatella Baronciani, Josu de la Fuente, Jacques-Emanuel Galimard, Arnaud Dalissier, Ashrafsadat Mousavi, Akif Yesilipek, Hasan Hashem, Gulyuz Ozturk, Franco Locatelli, Ali Alahmari, Javid Gaziev, Ali Bülent Antmen, O. Alphan Kupesiz, Tunc Fisgin, Giorgio La Nasa, Arjan C. Lankester, Eugene Goussetis, Sandrine Bremathas, Emanuele Angelucci

Blood (2024) 144 (Supplement 1): 2136.

https://doi.org/10.1182/blood-2024-208421

Published: 2024

Journal Articles

Significant Growth in HCT Use for Haemoglobinopathies in the Last Decade Driven By Sickle Cell Disease across All Ages with Excellent Outcomes: An Analysis of EBMT Haemoglobinopathies Working Party

Blood (2024) 144 (Supplement 1): 2184.

https://doi.org/10.1182/blood-2024-208191

Published: 2024

Journal Articles

Comparative Results of Pediatric Patients with ALL Receiving Either of Two Different Types of Human Anti-T Lymphocyte Globulin Prior to Hematopoietic Stem Cell Transplantation: Findings from the International Prospective Forum Study

Blood (2024) 144 (Supplement 1): 4864.

https://doi.org/10.1182/blood-2024-203358

Published: 2024

Journal Articles

Outcomes of hematopoietic stem cell transplantation in 813 pediatric patients with Fanconi anemia

Blood (2024) 144 (12): 1329–1342.

https://doi.org/10.1182/blood.2023022751

Published: 2024

Includes: Supplemental data

Journal Articles

Similar Overall Survival and Event-Free Survival for Patients Under or over the Age of 14 Years, but More Chronic Graft Versus Host Disease and Non-Relapse Mortality in the “Older” Patients

Dr. Peters, Peter Bader, Ulrike Pötschger, M. Akif Yesilipek, Herbert Pichler, Franco Locatelli, Raquel Staciuk, Adriana Balduzzi, Gergely Krivan, Marianne Ifversen, Cristina Díaz De Heredia, Marc Bierings, Jacek Wachowiak, Jean-Hugues Dalle

Blood (2023) 142 (Supplement 1): 3548.

https://doi.org/10.1182/blood-2023-185870

Published: 2023

Journal Articles

Outcome of Children with B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) with Hypodiploidy or BCR-ABL1 Fusion Given Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Results from the Prospective Forum Study

Blood (2023) 142 (Supplement 1): 1050.

https://doi.org/10.1182/blood-2023-187587

Published: 2023

Journal Articles

Relapse Is the Most Common Treatment Failure Post HSCT in Children with ALL below 4 Years of Age Given a Chemo-Based Conditioning Regimen. Results from the Prospective Multinational Forum-Trial

Christina Peters, Ulrike Poetschger, Jean-Hugues Dalle, Akif Yesilipek, Jerry Stein, Herbert Pichler, Adriana Balduzzi, Franco Locatelli, Petr Sedlacek, Jacek Wachowiak, Tayfun Güngör, Marianne Ifversen, Marleen Renard, Tony H Truong, Raquel Staciuk, Peter J. Shaw, Gergely Kriván, Jochen Büchner, Peter Bader

Blood (2022) 140 (Supplement 1): 897–899.

https://doi.org/10.1182/blood-2022-168609

Published: 2022

Journal Articles

Outcome of Haematopoietic Cell Transplantation in 813 Children with Fanconi Anaemia: A Study on Behalf of the EBMT Severe Aplastic Anaemia Working Party and Paediatric Disease Working Party

Blood (2022) 140 (Supplement 1): 657–659.

https://doi.org/10.1182/blood-2022-163140

Published: 2022

Journal Articles

Superior Graft-Versus-Leukemia Effect in Matched Unrelated Donor Versus HLA-Identical Sibling Pediatric Recipients Transplanted for Acute Lymphoblastic Leukemia within the Forum Study

Jean-Hugues Dalle, Peter Bader, Akif Yesilipek, Franco Locatelli, Julia Palma, Jacek Wachowiak, Herbert Pichler, Marianne Ifversen, Gergely Kriván, Jochen Buechner, Cristina Díaz-de-Heredia, Marc Bierings, Raquel Staciuk, Tayfun Gungor, Jacek Toporski, Adriana Balduzzi, Ulrike Poetschger, Christina Peters, Petr Sedlacek

Blood (2022) 140 (Supplement 1): 903–905.

https://doi.org/10.1182/blood-2022-164735

Published: 2022

Journal Articles

Stem Cell Transplantation for Diamond-Blackfan Anemia. a Retrospective Study on Behalf of Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT)

Blood (2019) 134 (Supplement_1): 44.

https://doi.org/10.1182/blood-2019-124644

Published: 2019

Journal Articles

Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? - a Multicenter EBMT-PDWP Study

Andre Manfred Willasch, MD, Christina Peters, MD, Petr Sedlacek, MD, Jean-Hugues Dalle, MD, Stelios Graphakos, MD, Akif Yesilipek, MD, Jacek Wachowiak, Prof MDPhD, Arjan Lankester, MD PhD, Arcangelo Prete, MD, Amir Ali Hamidieh, MD, Marianne Ifversen, Jochen Büchner, MDPhD, Gergely Krivan, MD, Rose-Marie Hamladji, MD, Cristina Diaz de Heredia, MD, Elena Skorobogatova, MD PhD, Gerard Michel, MD, Franco Locatelli, MD PhD, Alice Bertaina, MD PhD, Paul Veys, MD, Sophie Dupont, MD, Reuven Or, MD, Tayfun Guengoer, Olga Aleinikova, MD PhD, Sabina Sufliarska, MD, Mikael Sundin, MD PhD, Jelena Rascon, MD, Ain Kaare, MD, Damir Nemet, MD PhD, Franca Fagioli, MD, Thomas Klingebiel, MD, Jan Styczynski, PhD, Marc B Bierings, MDPhD, Kalman Nagy, MD, Manuel Abecasis, MD, Boris V Afanasyev, MD PhD Professor, Marc Ansari, MD, Arnaud Dalissier, Myriam Labopin, MD, Eric Beohou, Peter Bader, MD PhD

Blood (2017) 130 (Supplement 1): 911.

https://doi.org/10.1182/blood.V130.Suppl_1.911.911

Published: 2017

Journal Articles

Contemporary Conditioning Regimen before Allogeneic Stem Cell Transplantation for Children with Non-Malignant Diseases

Christina Peters, MD, Mary Slatter, MD, Paul Veys, MD Prof., Franco Locatelli, MD, Adriana Balduzzi, MD, M. Akif Yesilipek, Prof. Dr., Jean-Hugues Dalle, MD PhD Prof., Marina Cavazzana, MD PhD, Jaap Jan Boelens, MD PhD, Isaac Yaniv, MD Prof., Ansgar S Schulz, MD PhD Prof., Jacek Wachowiak, Prof MD PhD, Manfred Hoenig, MD, Arjan C Lankester, MD PhD, Benedicte Neven, MD PhD, Eric Beohou, Arnaud Dallisier, Peter Bader, MD, Andrew Gennery, MD

Blood (2016) 128 (22): 3398.

https://doi.org/10.1182/blood.V128.22.3398.3398

Published: 2016

Journal Articles

Turkish National Severe Congenital Neutropenia Registry

Blood (2016) 128 (22): 4916.

https://doi.org/10.1182/blood.V128.22.4916.4916

Published: 2016

Journal Articles

Risk Factors Affecting Outcome of Transplantation in Pediatric Acute Lymphoblastic Leukemia: Results of the International BFM ALL SCT Study

Adriana Balduzzi, MD, Jean-Hugues Dalle, MD PhD, Arjan C Lankester, MD PhD, Isaac Yaniv, MD, Akif Yesilipek, MD, Petr Sedlacek, MD PhD, Marianne Ifversen, MD, Sabina Sufliarska, MD, Marc B Bierings, MDPhD, Jacek Wachowiak, Prof MDPhD, Jacek Toporski, MD PhD, Ulrike Poetschger, Evgenia Glogova, Ingeborg Hirsch, BS, Christina Peters, MD PhD

Blood (2015) 126 (23): 2015.

https://doi.org/10.1182/blood.V126.23.2015.2015

Published: 2015

Journal Articles

Interim Results from a Phase 2, Multicenter, Single-Arm Study to Evaluate the Safety and Efficacy of Deferasirox after Hematopoietic Stem Cell Transplantation in Children with Beta-Thalassemia Major

M Akif Yesilipek, MD, Gulsun Karasu, MD, Zuhre Kaya, MD, Baris B Kuskonmaz, MD, Vedat Uygun, MD, Ilkiz Dag, MD, Asli Birkent, MD, Mehmet Ertem, MD

Blood (2015) 126 (23): 959.

https://doi.org/10.1182/blood.V126.23.959.959

Published: 2015

Journal Articles

Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation

Blood (2015) 126 (16): 1885–1892.

https://doi.org/10.1182/blood-2015-02-628859

Published: 2015

Journal Articles

Safety and Outcomes of Extracorporeal Photopheresis with the Therakos Cellex System for Graft Versus Host Disease in Pediatric Patients

Vedat Uygun, Hayriye Daloglu, Gulsun Karasu, MD, Volkan Hazar, MD, M. Akif Yesilipek, Prof. Dr.

Blood (2014) 124 (21): 5879.

https://doi.org/10.1182/blood.V124.21.5879.5879

Published: 2014

Journal Articles

Myeloablative Chemo-Conditioning for First Hematopoietic STEM CELL Transplantation in Children with ACUTE Lymphoblastic Leukemia in First or Second Remission

Christina Peters, MD Professor of Paediatrics, Jean-Hugues Dalle, MD PhD, Stelios Graphakos, MD Assoc. Professor of Paediatric Haematology, Petr Sedlacek, Prof., MD PhD, Antonio Campos, MD, M. Akif Yesilipek, Prof. Dr., Jacek Wachowiak, MD PhD, Arjan C. Lankester, MD PhD, Andrea Pession, Amir Ali Hamidieh, MD, Marianne Ifversen, MD PhD, Jochen Büchner, MD PhD, Gergely Krivan, MD PhD, Franca Fagioli, MD, Arnaud Dalissier, Myriam Labopin, MD, Peter Bader

Blood (2014) 124 (21): 546.

https://doi.org/10.1182/blood.V124.21.546.546

Published: 2014

Journal Articles

The Cell Loss after Thawing in Cord Blood Units

Gulsun Karasu, MD, Vedat Uygun, Suar Caki Kilic, Zeynep Ozturk, Zeynep Dincer, M. Akif Yesilipek, Prof. Dr.

Blood (2014) 124 (21): 5833.

https://doi.org/10.1182/blood.V124.21.5833.5833

Published: 2014

Journal Articles

A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in β-thalassemia major (CORDELIA)

Dudley J. Pennell, John B. Porter, Antonio Piga, Yongrong Lai, Amal El-Beshlawy, Khawla M. Belhoul, Mohsen Elalfy, Akif Yesilipek, Yurdanur Kilinç, Tomasz Lawniczek, Dany Habr, Marianne Weisskopf, Yiyun Zhang, Yesim Aydinok

Blood (2014) 123 (10): 1447–1454.

https://doi.org/10.1182/blood-2013-04-497842

Published: 2014

Includes: Supplemental data

NARROW

Significant Growth in HCT Use for Haemoglobinopathies in the Last Decade Driven By Sickle Cell Disease across All Ages with Excellent Outcomes: An Analysis of EBMT Haemoglobinopathies Working Party

Comparative Results of Pediatric Patients with ALL Receiving Either of Two Different Types of Human Anti-T Lymphocyte Globulin Prior to Hematopoietic Stem Cell Transplantation: Findings from the International Prospective Forum Study

Outcomes of hematopoietic stem cell transplantation in 813 pediatric patients with Fanconi anemia

Similar Overall Survival and Event-Free Survival for Patients Under or over the Age of 14 Years, but More Chronic Graft Versus Host Disease and Non-Relapse Mortality in the “Older” Patients

Outcome of Children with B-Cell Precursor Acute Lymphoblastic Leukemia (BCP-ALL) with Hypodiploidy or BCR-ABL1 Fusion Given Allogeneic Hematopoietic Stem Cell Transplantation (HSCT): Results from the Prospective Forum Study

Relapse Is the Most Common Treatment Failure Post HSCT in Children with ALL below 4 Years of Age Given a Chemo-Based Conditioning Regimen. Results from the Prospective Multinational Forum-Trial

Outcome of Haematopoietic Cell Transplantation in 813 Children with Fanconi Anaemia: A Study on Behalf of the EBMT Severe Aplastic Anaemia Working Party and Paediatric Disease Working Party

Superior Graft-Versus-Leukemia Effect in Matched Unrelated Donor Versus HLA-Identical Sibling Pediatric Recipients Transplanted for Acute Lymphoblastic Leukemia within the Forum Study

Stem Cell Transplantation for Diamond-Blackfan Anemia. a Retrospective Study on Behalf of Severe Aplastic Anemia Working Party of the European Blood and Marrow Transplantation Group (EBMT)

Myeloablative Conditioning for First Allogeneic Hematopoietic Stem Cell Transplantation in Children with ALL: Total Body Irradiation or Chemotherapy? - a Multicenter EBMT-PDWP Study

Contemporary Conditioning Regimen before Allogeneic Stem Cell Transplantation for Children with Non-Malignant Diseases

Turkish National Severe Congenital Neutropenia Registry

Risk Factors Affecting Outcome of Transplantation in Pediatric Acute Lymphoblastic Leukemia: Results of the International BFM ALL SCT Study

Interim Results from a Phase 2, Multicenter, Single-Arm Study to Evaluate the Safety and Efficacy of Deferasirox after Hematopoietic Stem Cell Transplantation in Children with Beta-Thalassemia Major

Stem cell transplantation in severe congenital neutropenia: an analysis from the European Society for Blood and Marrow Transplantation

Safety and Outcomes of Extracorporeal Photopheresis with the Therakos Cellex System for Graft Versus Host Disease in Pediatric Patients

Myeloablative Chemo-Conditioning for First Hematopoietic STEM CELL Transplantation in Children with ACUTE Lymphoblastic Leukemia in First or Second Remission

The Cell Loss after Thawing in Cord Blood Units

A 1-year randomized controlled trial of deferasirox vs deferoxamine for myocardial iron removal in β-thalassemia major (CORDELIA)

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only